Back
Royalty Pharma Plc Stock Price Chart
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
52
RPRX
Royalty Pharma Plc
Last Price:
$39.14
Seasonality Move:
6.41%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is moderately bullish and RPRX is experiencing slight selling pressure.
Royalty Pharma Plc Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.64 | Sell |
| 20-day SMA: | 39.43 | Buy |
| 50-day SMA: | 37.6 | Buy |
| 200-day SMA: | 35.17 | Buy |
| 8-day EMA: | 39.58 | Buy |
| 20-day EMA: | 39.12 | Buy |
| 50-day EMA: | 38.08 | Buy |
| 200-day EMA: | 35.19 | Buy |
Royalty Pharma Plc Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.58 | Buy |
| Relative Strength Index (14 RSI): | 57.11 | Buy |
| Chaikin Money Flow: | -809388 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.94 - 40.04) | Buy |
| Bollinger Bands (100): | (35.58 - 38.36) | Buy |
Royalty Pharma Plc Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Royalty Pharma Plc Stock
Is Royalty Pharma Plc Stock a Buy?
-
Royalty Pharma Plc share price is 39.60 while RPRX 8-day simple moving average is 39.64, which is a Sell signal.
-
The stock price of RPRX is 39.60 while Royalty Pharma Plc 20-day SMA is 39.43, which makes it a Buy.
-
Royalty Pharma Plc 50-day simple moving average is 37.60 while RPRX share price is 39.60, making it a Buy technically.
-
RPRX stock price is 39.60 and Royalty Pharma Plc 200-day simple moving average is 35.17, creating a Buy signal.
RPRX Technical Analysis vs Fundamental Analysis
Buy
52
Royalty Pharma Plc (RPRX)
is a Buy
Is Royalty Pharma Plc a Buy or a Sell?
-
Royalty Pharma Plc stock is rated a BuyThe current Royalty Pharma Plc [RPRX] share price is $39.60. The Score for RPRX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Royalty Pharma Plc Stock Info
Market Cap:
16.9B
Price in USD:
39.60
Share Volume:
3.1M
Royalty Pharma Plc 52-Week Range
52-Week High:
41.24
52-Week Low:
24.05
Buy
52
Royalty Pharma Plc (RPRX)
is a Buy
Royalty Pharma Plc Share Price Forecast
-
What is the Royalty Pharma Plc stock price today?The Royalty Pharma Plc stock price is 39.60 USD today.
-
Will RPRX stock go up or go down?Royalty Pharma Plc> share price is forecast to RISE/FALL based on technical indicators
-
Is Royalty Pharma Plc overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Royalty Pharma Plc is not overvalued.
Is Royalty Pharma Plc Stock a Buy?
-
Royalty Pharma Plc share price is 39.60 while RPRX 8-day exponential moving average is 39.58, which is a Buy signal.
-
The stock price of RPRX is 39.60 while Royalty Pharma Plc 20-day EMA is 39.12, which makes it a Buy.
-
Royalty Pharma Plc 50-day exponential moving average is 38.08 while RPRX share price is 39.60, making it a Buy technically.
-
RPRX stock price is 39.60 and Royalty Pharma Plc 200-day simple moving average is 35.19, creating a Buy signal.
Fundamental Analysis of Royalty Pharma Plc
Is Royalty Pharma Plc a good investment?
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.41 per share.
Technical Analysis of Royalty Pharma Plc
Should I short Royalty Pharma Plc stock?
-
RPRX Moving Average Covergence Divergence (MACD) indicator is 0.58, suggesting Royalty Pharma Plc is a Buy
-
Royalty Pharma Plc Relative Strength Index (RSI) is 57.11, which suggest Royalty Pharma Plc is overbought
-
The Bollinger Bands (25) for Royalty Pharma Plc is (37.94 - 40.04), which suggest Royalty Pharma Plc is a Buy
-
The Bollinger Bands (100) for Royalty Pharma Plc is (35.58 - 38.36), which suggest Royalty Pharma Plc is a Buy
* Royalty Pharma Plc stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.